阿司匹林预防急性呼吸窘迫综合征/急性肺损伤效果的荟萃分析
该荟萃分析纳入6项对照研究共6562例有ARDS/ALI风险的成人患者,评估阿司匹林对ARDS/ALI发生率和死亡率的影响。结果显示阿司匹林可降低ARDS/ALI发生率(OR 0.71,95%CI 0.58-0.86),但死亡率无显著差异(OR 0.87,95%CI 0.71-1.07)。结局指标未发现显著异质性。结论提示阿司匹林对ARDS/ALI发生有保护作用,但不能降低死亡率。
要点
- 在具有ARDS/ALI风险的成人患者中,阿司匹林降低ARDS/ALI发生率(OR 0.71,95%CI 0.58-0.86)。
- 阿司匹林未降低死亡率(OR 0.87,95%CI 0.71-1.07),95%CI跨1,未达统计学显著。
- 汇总6项对照研究共6562例成人患者,结局指标未发现显著异质性。
- 阿司匹林对ARDS/ALI发生有保护作用,但不能降低死亡率。
适用人群与场景
- 具有ARDS/ALI风险的成人患者。
研究设计与关键结果
- 研究类型为荟萃分析,纳入6项对照研究,共6562例具有ARDS/ALI风险的成人患者。
- 阿司匹林降低ARDS/ALI发生率(OR 0.71,95%CI 0.58-0.86)。
- 阿司匹林未降低死亡率(OR 0.87,95%CI 0.71-1.07),95%CI跨1,未达统计学显著。
- 结局指标未发现显著异质性。
证据类型、等级与局限
- 证据类型为荟萃分析,汇总6项对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在具有ARDS/ALI风险的成人患者中,阿司匹林可能降低ARDS/ALI发生率,但未降低死亡率。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The effects of aspirin in preventing the occurrence of acute respiratory distress syndrome (ARDS)/acute lung injury (ALI) among adult patients are controversial. We aimed to further determine the effectiveness of aspirin in reducing the rate of ARDS/ALI.
METHODS: The Pubmed, Embase, Medline, ClinicalTrials.gov, Cochrane Central Register of Controlled Trials (CENTRAL) as well as the Information Sciences Institute (ISI) Web of Science were searched for all controlled studies that research the role of aspirin in adult patients who have the risk of ARDS/ALI. The outcomes were the ARDS/ALI rate and the mortality. Cochrane systematic review software, Review Manager (RevMan), the R software for statistical computing version 3.2.0, and the metafor package were used to test the hypothesis by Mann-Whitney U test. The heterogeneity test and sensitivity analyses were conducted, and random-effects or fixed-effects model was applied to calculate odds ratio (OR) and mean difference (MD) for dichotomous and continuous data, respectively.
RESULTS: Six trials involving 6562 patients were pooled in our final study. No significant heterogeneity was found in outcome measures. Aspirin could reduce the rate of ARDS/ALI (OR 0.71, 95% confidence interval (CI) 0.58-0.86) but not the mortality (OR 0.87, 95% CI 0.71-1.07).
CONCLUSIONS: In patients with risk of ARDS/ALI, aspirin could provide protective effect on the rate of ARDS/ALI, but it could not reduce the mortality.
参考来源
- Yu H, Ni YN, Liang ZA, et al. The effect of aspirin in preventing the acute respiratory distress syndrome/acute lung injury: A meta-analysis. Am J Emerg Med. 2018. PMID: 29804790. doi:10.1016/j.ajem.2018.05.017
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。